Nanoparticle-formulated drug combination is effective in medulloblastoma, a pediatric brain tumor

Researchers have demonstrated that a novel combination of two drugs that act as targeted inhibitors, delivered in a nanoparticle formulation, extend the survival of mice with medulloblastoma. The research team believes this laboratory success could be translated into a less toxic treatment for medulloblastoma, the most common malignant pediatric brain tumor.

Read more: https://www.sciencedaily.com/releases/2022/01/220126144237.htm